Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
ACET holding history
Adicet Bio, Inc. in every 13F filed by Johnson & Johnson, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACET overviewAll 13F holders of ACETFull Q2 2026 holdings
- Shares (Q2 2026)
- 22,779
- Value
- $196.8K
- % of portfolio
- <0.1%
- Quarters held
- 20
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 22,779 | $196.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 22,779 | $155.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 22,779 | $191.8K | <0.1% | −341,693−93.8% | Reduced | Holders |
| Q3 2025 | 364,472 | $295.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 364,472 | $228.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 364,472 | $275.2K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 364,472 | $350.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 364,472 | $524.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 364,472 | $441.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 364,472 | $856.5K | <0.1% | −324,123−47.1% | Reduced | Holders |
| Q4 2023 | 688,595 | $1.30M | <0.1% | −40,349−5.5% | Reduced | Holders |
| Q3 2023 | 728,944 | $998.7K | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2023 | 728,944 | $1.77M | 0.5% | 00.0% | Unchanged | Holders |
| Q1 2023 | 728,944 | $4.20M | 1.4% | 00.0% | Unchanged | Holders |
| Q4 2022 | 728,944 | $6.52M | 1.9% | 00.0% | Unchanged | Holders |
| Q3 2022 | 728,944 | $10.4M | 3.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 728,944 | $10.6M | 2.7% | 00.0% | Unchanged | Holders |
| Q1 2022 | 728,944 | $14.6M | 2.8% | 00.0% | Unchanged | Holders |
| Q4 2021 | 728,944 | $12.7M | 1.5% | 00.0% | Unchanged | Holders |
| Q3 2021 | 728,944 | $5.71M | 0.5% | – | No prior filing | Holders |